本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

15.04
-0.8500-5.35%
盤前15.040.00000.00%05:29 EDT
成交量:256.83萬
成交額:3,868.10萬
市值:21.36億
市盈率:-42.75
高:15.88
開:15.88
低:14.78
收:15.89
52周最高:20.22
52周最低:7.92
股本:1.42億
流通股本:1.18億
量比:1.90
換手率:2.18%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.64
市盈率(LYR):-47.40

資料載入中...

2024/04/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

SEC問詢函

Form CORRESP - Correspondence
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/29

重要事件披露

Form 8-K - Current report
2023/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report